The CyberKnife® S7™ FIM System is a non-invasive treatment for various cancers and conditions where radiation therapy is needed. It treats tumours throughout the body, including the brain, lungs, spine, prostate, and abdomen. It can be an alternative to surgery for patients with inoperable or complex tumours. Even patients previously treated with radiation or with metastatic or recurrent cancers can receive CyberKnife® S7™ FIM treatment. CyberKnife® S7™ FIM treatments are typically performed in 1 to 5 sessions. Treatment sessions are non- invasive outpatient procedures, and no anaesthesia or incisions are required, enabling most patients to continue with daily activities over the course of treatment. The CyberKnife® System has been shown to deliver excellent cancer control with reduced risk of side effects through more than two decades of clinical proof and successful treatment of millions of cancer patients.
The treatment process begins with a consultation between the patient, radiation oncologist and medical care team to decide the best treatment option. The CyberKnife® S7™ FIM System team will conduct a series of scans necessary to build a precise treatment plan. Depending on tumour location, preparation may require additional accessories to make treatment more comfortable. Sometimes treatment may require the placement of fiducials, or markers, to pinpoint the tumour's exact location. The care team will be there to explain each step along the way
Treatment sessions are outpatient procedures that do not require incisions or general anaesthesia. Treatment takes place in a dedicated treatment room with a specially trained team. Treatments can take as little as 15 minutes, depending on the tumour to treat. During treatment, patients breathe normally while the robot moves quietly around the body to deliver radiation precisely to the tumour.
Most patients experience very few side effects and continue normal activity throughout treatment. The care team will schedule a follow-up visit about a month after treatment ends to assess the patient’s response and address any side effects, should they occur.